Javorský M - Search Results

1

KCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors.

Gotthardová I, Javorský M, Klimčáková L, Kvapil M, Schroner Z, Kozárová M, Malachovská Z, Ürgeová A, Židzik J, Tkáč I. Gotthardová I, et al. Among authors: javorsky m. Diabetes Res Clin Pract. 2017 Aug;130:142-147. doi: 10.1016/j.diabres.2017.05.018. Epub 2017 May 19. Diabetes Res Clin Pract. 2017. PMID: 28624668

2

Increased intracranial arterial resistance in patients with type 2 diabetes mellitus.

Tkác I, Troscák M, Javorský M, Petrík R, Tomcová M. Tkác I, et al. Among authors: javorsky m. Wien Klin Wochenschr. 2001 Nov 15;113(22):870-3. Wien Klin Wochenschr. 2001. PMID: 11762124

3

Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus.

Tkác I, Salagovic J, Kozárová M, Javorský M, Tkácová R, Kalina I. Tkác I, et al. Among authors: javorsky m. Wien Klin Wochenschr. 2003 Dec 15;115(23):835-9. doi: 10.1007/BF03041044. Wien Klin Wochenschr. 2003. PMID: 14740347

4

Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients.

Javorský M, Kozárová M, Salagovic J, Tkáč I. Javorský M, et al. Physiol Res. 2006;55(1):55-62. doi: 10.33549/physiolres.930704. Epub 2005 Apr 26. Physiol Res. 2006. PMID: 15857159 Free article.

5

Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.

Stancáková A, Baldaufová L, Javorský M, Kozárová M, Salagovic J, Tkác I. Stancáková A, et al. Among authors: javorsky m. Physiol Res. 2006;55(5):483-490. doi: 10.33549/physiolres.930836. Epub 2005 Dec 12. Physiol Res. 2006. PMID: 16343038 Free article.

6

Fenofibrate treatment reduces circulating conjugated diene level and increases glutathione peroxidase activity.

Tkác I, Molcányiová A, Javorský M, Kozárová M. Tkác I, et al. Among authors: javorsky m. Pharmacol Res. 2006 Mar;53(3):261-4. doi: 10.1016/j.phrs.2005.12.002. Epub 2006 Jan 18. Pharmacol Res. 2006. PMID: 16420979 Clinical Trial.

7

Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.

Molcányiová A, Stancáková A, Javorský M, Tkác I. Molcányiová A, et al. Among authors: javorsky m. Pharmacol Res. 2006 Sep;54(3):203-7. doi: 10.1016/j.phrs.2006.04.009. Epub 2006 May 4. Pharmacol Res. 2006. PMID: 16737822

8

Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease.

Javorský M, Gasperíková D, Ukropec J, Sedláková B, Riecanský I, Krizanová O, Seböková E, Dobríková M, Klimes I, Tkác I. Javorský M, et al. Wien Klin Wochenschr. 2007;119(15-16):476-82. doi: 10.1007/s00508-007-0824-1. Wien Klin Wochenschr. 2007. PMID: 17721767

9

Relationship of five type 2 diabetes candidate gene polymorphisms to the age at diagnosis of diabetes in the Slovakian population.

Kozarova M, Javorsky M, Stancakova A, Dobrikova M, Habalova V, Klimcakova L, Zidzik J, Haluskova J, Salagovic J, Tkac I. Kozarova M, et al. Among authors: javorsky m. Bratisl Lek Listy. 2010;111(3):150-2. Bratisl Lek Listy. 2010. PMID: 20437825

10

Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes.

Schroner Z, Javorsky M, Tkacova R, Klimcakova L, Dobrikova M, Habalova V, Kozarova M, Zidzik J, Rudikova M, Tkac I. Schroner Z, et al. Among authors: javorsky m. Diabetes Obes Metab. 2011 Jan;13(1):89-91. doi: 10.1111/j.1463-1326.2010.01324.x. Diabetes Obes Metab. 2011. PMID: 21114608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters